Paper21998477
Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.
Ohmit SE and 4 others. J Infect Dis, 2011. Cited by 255 papers, by iCite.
Cite this record
ConductScience Library. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. Papers, record 21998477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21998477
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Viral | Major topic |
| Influenza A Virus, H3N2 Subtype | Major topic |
| Influenza Vaccines | Major topic |
| Influenza, Human | Major topic |
| Adolescent | |
| Adult | |
| Female | |
| Hemagglutination Inhibition Tests | |
| Humans | |
| Male | |
| Middle Aged | |
| Titrimetry | |
| Vaccines, Attenuated | |
| Vaccines, Inactivated | |
| Young Adult |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00538512 | Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4 | Results | Yes |
Source ClinicalTrials.gov
Cited by189
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 255 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923137 | Exercise, physical activity, physical fitness, and humoral responses to influenza vaccination in adults: a systematic review and meta-analysis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42923137 | PubMed |
| 42921512 | Humoral Immunogenicity of mRNA-1010, an mRNA-based Seasonal Influenza Vaccine, in Adults ≥50 Years. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/42921512 | PubMed |
| 42695687 | Linear DNA expression cassette encapsulated in lipid nanoparticles confers complete protection against influenza A virus in mice. | mSphere | 2026 | https://conductscience.org/library/papers/42695687 | PubMed |
| 42562831 | Influenza. | Nat Rev Dis Primers | 2026 | https://conductscience.org/library/papers/42562831 | PubMed |
| 42546126 | A bivalent inactivated influenza vaccine incorporating epitope-optimized surface proteins confers cross-protective immunity against H9N2 influenza virus. | Emerg Microbes Infect | 2026 | https://conductscience.org/library/papers/42546126 | PubMed |
| 42415697 | Dynamics of Circulating Follicular Helper and Regulatory T-Cell Memory Induced by mRNA, Inactivated, and Live-Attenuated Vaccines. | J Immunol Res | 2026 | https://conductscience.org/library/papers/42415697 | PubMed |
| 41990070 | Assessment of hemagglutinin-inhibition activity following influenza vaccination during the 2022-2023, 2023-2024, and 2024-2025 seasons. | PLoS One | 2026 | https://conductscience.org/library/papers/41990070 | PubMed |
| 41929310 | Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018-May 2019. | medRxiv | 2026 | https://conductscience.org/library/papers/41929310 | PubMed |
| 41794097 | Measurement of the absolute mass concentration of antigen-specific serum IgG via quantitative Western blotting. | Anal Biochem | 2026 | https://conductscience.org/library/papers/41794097 | PubMed |
| 41778892 | Use of the test-negative design to estimate the protective effect of a scalar immune measure: a simulation analysis. | Am J Epidemiol | 2026 | https://conductscience.org/library/papers/41778892 | PubMed |
| 41725518 | High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains. | Elife | 2026 | https://conductscience.org/library/papers/41725518 | PubMed |
| 41383614 | Synthetic DNA co-immunization with vaccine-aligned common consensus nucleoprotein and hemagglutinin protects mice against lethal influenza infection with a single immunization. | Front Immunol | 2025 | https://conductscience.org/library/papers/41383614 | PubMed |
| 41287634 | Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025. | Virus Evol | 2025 | https://conductscience.org/library/papers/41287634 | PubMed |
| 41249826 | Replication in human cells supersedes serum antigenic match for the in vivo efficacy of an A/H1N1pdm09 LAIV virus. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/41249826 | PubMed |
| 41202613 | Assessing factors associated with one-year antibody waning in participants with repeated influenza vaccinations: A six-year cohort study. | Vaccine | 2025 | https://conductscience.org/library/papers/41202613 | PubMed |
| 41166714 | Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adults. | J Immunol | 2026 | https://conductscience.org/library/papers/41166714 | PubMed |
| 40950014 | Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025. | bioRxiv | 2025 | https://conductscience.org/library/papers/40950014 | PubMed |
| 40872944 | Immunogenicity as a Predictor of Influenza Vaccine Efficacy: A Systematic Review. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40872944 | PubMed |
| 40667976 | Development of DNA and mRNA-LNP vaccines against an H5N1 clade 2.3.4.4b influenza virus. | J Virol | 2025 | https://conductscience.org/library/papers/40667976 | PubMed |
| 40662851 | First Among Equals: The Case for High-quality Clinical Data in Influenza Vaccines. | Clin Infect Dis | 2025 | https://conductscience.org/library/papers/40662851 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21998477
GET https://conductscience.org/api/papers/v1/21998477/cited_by?page=2